NEW YORK, Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or the "Company") (NASDAQ: MYNA) and certain officers.  The class action, filed in the United States District Court for the Eastern District Of New York, and docketed under 24-cv-07602 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Mynaric securities between June 20, 2024 and October 7, 2024, both da ...

Core Viewpoint - A class action lawsuit has been filed against Mynaric AG for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Eastern District of New York on behalf of all individuals and entities who purchased Mynaric securities between June 20, 2024, and October 7, 2024 [1]. - Investors have until December 30, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Allegations Against Mynaric - The complaint alleges that Mynaric's management made false and misleading statements about the company's business and operations [3]. - Specific issues cited include lower-than-expected production yields and component supplier shortages leading to production delays for Mynaric's CONDOR Mk3 product [3]. - These production issues are expected to have a material negative impact on the company's revenue growth and could result in an operating loss [3]. - As a consequence, Mynaric is unlikely to meet its previously issued financial guidance for FY 2024, indicating that the company's business and financial prospects were overstated [3].

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Mynaric investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley ...

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mynaric securities ...

SAN DIEGO, Oct. 31, 2024 /PRNewswire/ -- Robbins LLP announces that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Mynaric AG (NASDAQ: MYNA) securities between June 20, 2024 and October 7, 2024. Mynaric develops and manufactures laser communication products for aerospace-based communication networks for government and commercial markets in the U.S. and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give ...

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company’s business, operations, and prospects, including allegations that: (i) lower-than-expected production yields and component supplier shortages of key components were causing production delays for ...

Shipments will support the Space Development Agency's Tranche 1 program MUNICH, Sept. 16, 2024 /PRNewswire/ -- Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced the successful advancement of the company's volume production ramp for the CONDOR Mk3. Mynaric continues to work through previously announced production delays and has realized near-term improvement in production yields and supply chain-related bottlen ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mynaric AG ("Mynaric" or "the Company") (NASDAQ: MYNA). Investors who purchased Mynaric securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MYNA. Investigation Details On August 20, 2024, Mynaric reduced its 2024 financial guidance. The Company blamed the change on produc ...

Core Insights - Mynaric AG has revised its full-year 2024 revenue guidance down to a range of EUR 16.0 million to EUR 24.0 million from a previous range of EUR 50.0 million to EUR 70.0 million due to production delays and component shortages [2] - The company also expects a higher operating loss for 2024, now projected to be between EUR 55.0 million to EUR 50.0 million, compared to the earlier guidance of a loss between EUR 40.0 million to EUR 30.0 million [2] - Following the announcement, Mynaric's stock price experienced a significant decline of $2.32 per share, or 55.9%, closing at $1.83 per share on August 20, 2024 [2] Company Developments - Mynaric announced the voluntary departure of CFO Stefan Berndt von-Bülow for personal reasons, effective the week prior to the announcement [2] - Bragar Eagel & Squire, P.C. is investigating potential claims against Mynaric on behalf of stockholders regarding possible violations of federal securities laws and other unlawful business practices [1]

SAN DIEGO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Mynaric AG (NASDAQ: MYNA) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Mynaric securities? If you purchased securities and suffered losses on your ...